Alessandra Ferrajoli

Research output

Research output per year 1990 2003 2006 2009 2010 2011 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 303 Article
• 29 Review article
• 24 Letter
• 4 Comment/debate
• 5 More
  • 2 Chapter
  • 2 Editorial
  • 1 Short survey

Research output per year

Research output per year

Search results

• 2023

  Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring

  Bataller, A., Haddad, F. G., Issa, G. C., Sasaki, K., Jabbour, E., Borthakur, G., Ferrajoli, A. & Short, N. J., 2023, In: Leukemia and Lymphoma. 64, 3, p. 746-749 4 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• Tolerability of acalabrutinib in patients with CLL: experience of a tertiary cancer care center

  McGhie, A., Lee, J., Ferrajoli, A. & DiPippo, A. J., 2023, In: Leukemia and Lymphoma. 64, 5, p. 1050-1053 4 p.

  Research output: Contribution to journal › Letter › peer-review
• 2021

  Ibrutinib induces durable remissions in treatment-naïve patients with CLL and 17p deletion and/or TP53 mutations

  Sivina, M., Kim, E., Wierda, W. G., Ferrajoli, A., Jain, N., Thompson, P., Kantarjian, H., Keating, M. & Burger, J. A., Dec 16 2021, In: Blood. 138, 24, p. 2589-2592 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  15 Scopus citations

• Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens

  Maiti, A., Rausch, C. R., Cortes, J. E., Pemmaraju, N., Daver, N. G., Ravandi, F., Garcia-Manero, G., Borthakur, G., Naqvi, K., Ohanian, M., Short, N. J., Alvarado, Y., Kadia, T. M., Takahashi, K., Yilmaz, M., Jain, N., Kornblau, S., Montalban-Bravo, G., Sasaki, K., Andreeff, M., & 15 othersBose, P., Ferrajoli, A., Issa, G. C., Jabbour, E. J., Masarova, L., Thompson, P. A., Wang, S., Konoplev, S., Pierce, S. A., Ning, J., Qiao, W., Welch, J. S., Kantarjian, H. M., DiNardo, C. D. & Konopleva, M. Y., Mar 2021, In: Haematologica. 106, 3, p. 894-898 5 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  73 Scopus citations

• Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia

  Maiti, A., DiNardo, C. D., Daver, N. G., Rausch, C. R., Ravandi, F., Kadia, T. M., Pemmaraju, N., Borthakur, G., Bose, P., Issa, G. C., Short, N. J., Yilmaz, M., Montalban-Bravo, G., Ferrajoli, A., Jabbour, E. J., Jain, N., Ohanian, M., Takahashi, K., Thompson, P. A., Loghavi, S., & 5 othersMontalbano, K. S., Pierce, S., Wierda, W. G., Kantarjian, H. M. & Konopleva, M. Y., Feb 2021, In: Blood cancer journal. 11, 2, 25.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  80 Scopus citations
• 2020

  Achieving complete remission in CLL patients treated with ibrutinib: Clinical significance and predictive factors

  Strati, P., Schlette, E. J., Solis Soto, L. M., Duenas, D. E., Sivina, M., Kim, E., Keating, M. J., Wierda, W. G., Ferrajoli, A., Kantarjian, H., Estrov, Z., Jain, N., Thompson, P. A., Wistuba, I. I. & Burger, J. A., Feb 13 2020, In: Blood. 135, 7, p. 510-513 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  8 Scopus citations

• First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)

  Alfayez, M., Thakral, B., Jain, P., Ravandi, F., Ferrajoli, A., Jain, N., Pemmaraju, N., Wierda, W. & Kadia, T., Jan 28 2020, In: Leukemia and Lymphoma. 61, 2, p. 445-449 5 p.

  Research output: Contribution to journal › Letter › peer-review
  10 Scopus citations

• Metastatic lung adenocarcinoma mimicking Richter transformation in a patient with chronic lymphocytic leukemia

  Cherng, H. J. J., Jain, N., Thakral, B., Muzzafar, T., Miranda, R. N., Tan, D., Rashid, A., Kalhor, N., Hahn, A. W., Byers, L. A., Parseghian, C. M., Ferrajoli, A. & Pemmaraju, N., Nov 2020, In: Leukemia Research. 98, 106445.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  2 Scopus citations
• 2019

  A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia

  Paul, S., Jain, N., Ferrajoli, A., O'Brien, S., Burger, J., Keating, M. & Wierda, W., May 2019, In: British Journal of Haematology. 185, 3, p. 606-608 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  11 Scopus citations

• Co-occurrence of chronic myeloid leukemia with chronic lymphocytic leukemia: a report of two cases

  Boddu, P., Gibbons, J., Burger, J., Sivina, M., Thakral, B., Kanagal-Shamanna, R. & Ferrajoli, A., May 12 2019, In: Leukemia and Lymphoma. 60, 6, p. 1568-1571 4 p.

  Research output: Contribution to journal › Letter › peer-review
  7 Scopus citations

• Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia

  Strati, P., Gabutti, C., Thompson, P. A., Kontoyiannis, D. P. & Ferrajoli, A., Jan 28 2019, In: Leukemia and Lymphoma. 60, 2, p. 535-537 3 p.

  Research output: Contribution to journal › Letter › peer-review

• The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype

  Strati, P., Wang, F., Tambaro, F. P., Thompson, P. A., Burger, J. A., Jain, N., Ferrajoli, A., Bose, P., Estrov, Z., Keating, M. J., Futreal, A., Takahashi, K. & Wierda, W. G., Oct 1 2019, In: British Journal of Haematology. 187, 1, p. e1-e4

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  3 Scopus citations
• 2018

  Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation

  Sivina, M., Werner, L., Rassenti, L., Ferrajoli, A., Wierda, W. G., Keating, M. J., O'Brien, S., Neuberg, D., Kipps, T. & Burger, J. A., Feb 2018, In: British Journal of Haematology. 180, 4, p. 597-600 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  5 Scopus citations
• 2017

  Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia

  Ten Hacken, E., Gounari, M., Back, J. W., Shimanovskaya, E., Scarfò, L., Kim, E., Burks, J., Ponzoni, M., Ramirez, G. A., Wierda, W. G., Estrov, Z., Keating, M. J., Ferrajoli, A., Stamatopoulos, K., Ghia, P. & Burger, J. A., Sep 30 2017, In: Haematologica. 102, 10, p. e394-e396

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  10 Scopus citations

• Consolidation treatment with lenalidomide following front-line or salvage chemoimmunotherapy in chronic lymphocytic leukemia

  Strati, P., Keating, M. J., Burger, J. A., O’Brien, S. M., Wierda, W. G., Estrov, Z., Zacharian, G. & Ferrajoli, A., Nov 30 2017, In: Haematologica. 102, 12, p. e494-e496

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  8 Scopus citations

• Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma

  Short, N. J., Kantarjian, H. M., Ko, H., Khoury, J. D., Ravandi, F., Thomas, D. A., Garcia-Manero, G., Khouri, M., Cortes, J. E., Wierda, W. G., Verstovsek, S., Estrov, Z., Ferrajoli, A., Thompson, P. A., Pierce, S., O'Brien, S. M. & Jabbour, E., Jun 2017, In: American journal of hematology. 92, 6, p. E114-E117

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  29 Scopus citations

• Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia

  Maiti, A., Cortes, J., Ferrajoli, A., Estrov, Z., Borthakur, G., Garcia-Manero, G., Jabbour, E., Ravandi, F., O’Brien, S. & Kantarjian, H., Sep 2 2017, In: Leukemia and Lymphoma. 58, 9, p. 2240-2242 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  8 Scopus citations
• 2016

  Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib

  Vitale, C., Ahn, I. E., Sivina, M., Ferrajoli, A., Wierda, W. G., Estrov, Z., Konoplev, S. N., Jain, N., O’Brien, S., Farooqui, M., Keating, M. J., Wiestner, A. & Burger, J. A., May 31 2016, In: Haematologica. 101, 6, p. e254-e258

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  41 Scopus citations
• 2015

  A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia

  Strati, P., Tong, W. G., Vitale, C., Wierda, W. G., O'Brien, S., Brown, J. R., Weng, W. K., Kipps, T., Keating, M. J. & Ferrajoli, A., Jun 1 2015, In: Leukemia and Lymphoma. 56, 6, p. 1878-1880 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  4 Scopus citations

• Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia

  Alattar, M. L., Ciccone, M., Gaballa, M. R., Vitale, C., Badoux, X. C., Manoukian, G., Keating, M. J., Kroll, M. H. & Ferrajoli, A., Dec 2 2015, In: Leukemia and Lymphoma. 56, 12, p. 3452-3454 3 p.

  Research output: Contribution to journal › Letter › peer-review
  7 Scopus citations

• The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy - the MD Anderson Cancer Center experience

  Thompson, P. A., Rozovski, U., Keating, M. J., Stingo, F., Smith, S. C., Wierda, W. G., Falchi, L., O'Brien, S. M., Estrov, Z., Burger, J. A. & Ferrajoli, A., Oct 1 2015, In: British Journal of Haematology. 171, 2, p. 281-284 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  4 Scopus citations
• 2013

  Central nervous system Richter's transformation and parvovirus B19 infection

  Jain, P., Benjamini, O., Pei, L., Caraway, N. P., Landon, G., Kim, S., Shivaprasad, S., Woodman, K., O'Brien, S., Ferrajoli, A., Kadia, T. & Estrov, Z., Sep 2013, In: Leukemia and Lymphoma. 54, 9, p. 2070-2072 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  3 Scopus citations
• 2006

  Author reply [4]

  Ferrajoli, A., Letilovic, T. & Vrhovac, R., Dec 1 2006, In: Cancer. 107, 11, p. 2743 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Cardiotoxicity in African-American patients treated with arsenic trioxide for acute promyelocytic leukemia [2]

  Patel, S. P., Garcia-Manero, G., Ferrajoli, A., Faderl, S., Verstovek, S., Kantarjian, H. & Estey, E., Mar 2006, In: Leukemia Research. 30, 3, p. 362-363 2 p.

  Research output: Contribution to journal › Letter › peer-review
  9 Scopus citations